Detalhe da pesquisa
1.
Effectiveness and safety of Dabigatran 110 mg versus 150 mg for Stroke Prevention in Patients with Atrial Fibrillation at High Bleeding Risk.
Clin Ther
; 45(7): e151-e158, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37380555
2.
Association of Direct Oral Anticoagulation Management Strategies With Clinical Outcomes for Adults With Atrial Fibrillation.
JAMA Netw Open
; 6(7): e2321971, 2023 Jul 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37410461
3.
Long-Term Medication Adherence Trajectories to Direct Oral Anticoagulants and Clinical Outcomes in Patients With Atrial Fibrillation.
J Am Heart Assoc
; 10(21): e021601, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34713708
4.
Warfarin Management and Outcomes in Patients with Nonvalvular Atrial Fibrillation Within an Integrated Health Care System.
J Manag Care Spec Pharm
; 23(6): 700-712, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28530526
5.
Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice.
J Am Heart Assoc
; 4(7)2015 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-26187996